Invesaro

Stocks Comparison

Charles River Laboratories International vs Nrc Health: revenue, profit, margins and growth compared

Charles River Laboratories International brought in $4B of revenue in fiscal 2025, Nrc Health $137.4M in fiscal 2025. Revenue changed by -0.9% at Charles River Laboratories International and -4.0% at Nrc Health on the year before, so Charles River Laboratories International grew faster. Charles River Laboratories International kept -3.6% of its revenue as net profit, Nrc Health 8.2%. Free cash flow was $518.5M at Charles River Laboratories International and $15.7M at Nrc Health.

Open the CRL pageOpen the NRC page

Side by side, latest fiscal year

CRLNRC
Fiscal year endedFY2025 (December 27, 2025)FY2025 (December 31, 2025)
Revenue$4B$137.4M
Revenue growth-0.9%-4.0%
Net income-$144.3M$11.3M
Net margin-3.6%8.2%
Free cash flow$518.5M$15.7M
Free cash flow margin12.9%11.5%
Earnings per share (diluted)-$2.91$50.00
Cash$213.8M$4.1M
Debt$166K$79M
Price to earningsn/a0.4
Market value$14B$432.9M
Dividend yieldn/a2.66%
Rank by revenue in sector#72 of 523 · Health care#278 of 523 · Health care

Over the years

Revenue
CRL FY2018: $2.3BCRL FY2019: $2.6BCRL FY2020: $2.9BCRL FY2021: $3.5BCRL FY2022: $4BCRL FY2023: $4.1BCRL FY2024: $4BCRL FY2025: $4BNRC FY2018: $119.7MNRC FY2019: $128MNRC FY2020: $133.3MNRC FY2021: $148MNRC FY2022: $151.6MNRC FY2023: $148.6MNRC FY2024: $143.1MNRC FY2025: $137.4MFY18FY19FY20FY21FY22FY23FY24FY25
CRL $4BNRC $137.4M
Net income
CRL FY2018: $226.4MCRL FY2019: $252MCRL FY2020: $364.3MCRL FY2021: $391MCRL FY2022: $486.2MCRL FY2023: $474.6MCRL FY2024: $22.2MCRL FY2025: -$144.3MNRC FY2018: $30MNRC FY2019: $32.4MNRC FY2020: $37.2MNRC FY2021: $37.4MNRC FY2022: $31.8MNRC FY2023: $31MNRC FY2024: $24.8MNRC FY2025: $11.3MFY18FY19FY20FY21FY22FY23FY24FY25
CRL -$144.3MNRC $11.3M
Net margin
CRL FY2018: 10.0%CRL FY2019: 9.6%CRL FY2020: 12.5%CRL FY2021: 11.0%CRL FY2022: 12.2%CRL FY2023: 11.5%CRL FY2024: 0.5%CRL FY2025: -3.6%NRC FY2018: 25.1%NRC FY2019: 25.3%NRC FY2020: 27.9%NRC FY2021: 25.3%NRC FY2022: 21.0%NRC FY2023: 20.8%NRC FY2024: 17.3%NRC FY2025: 8.2%FY18FY19FY20FY21FY22FY23FY24FY25
CRL -3.6%NRC 8.2%
Revenue growth
CRL FY2019: +15.7%CRL FY2020: +11.5%CRL FY2021: +21.1%CRL FY2022: +12.3%CRL FY2023: +3.9%CRL FY2024: -1.9%CRL FY2025: -0.9%NRC FY2019: +6.9%NRC FY2020: +4.1%NRC FY2021: +11.0%NRC FY2022: +2.4%NRC FY2023: -2.0%NRC FY2024: -3.7%NRC FY2025: -4.0%FY19FY20FY21FY22FY23FY24FY25
CRL -0.9%NRC -4.0%
Free cash flow
CRL FY2018: $301.1MCRL FY2019: $340.4MCRL FY2020: $380MCRL FY2021: $532MCRL FY2022: $294.9MCRL FY2023: $365.4MCRL FY2024: $501.6MCRL FY2025: $518.5MNRC FY2018: $33.9MNRC FY2019: $36.3MNRC FY2020: $36.7MNRC FY2021: $40.8MNRC FY2022: $26.4MNRC FY2023: $22.3MNRC FY2024: $19.2MNRC FY2025: $15.7MFY18FY19FY20FY21FY22FY23FY24FY25
CRL $518.5MNRC $15.7M

Fiscal years as each company reports them; the two may end in different months.

Questions about Charles River Laboratories International and Nrc Health

Which is bigger by revenue, Charles River Laboratories International or Nrc Health?

Charles River Laboratories International is bigger by revenue: $4B in fiscal 2025, against $137.4M for Nrc Health in fiscal 2025.

Which keeps more of its revenue as profit, Charles River Laboratories International or Nrc Health?

Charles River Laboratories International had a net margin of -3.6% in fiscal 2025; Nrc Health had 8.2% in fiscal 2025.

Which grew revenue faster, Charles River Laboratories International or Nrc Health?

In their latest fiscal years revenue changed by -0.9% at Charles River Laboratories International and -4.0% at Nrc Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

CRL vs IQV
CRL vs ICLR
CRL vs INCY
CRL vs MEDP
IQV vs NRC
ICLR vs NRC
INCY vs NRC

Compare more companies